Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Maria Baer
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Procedures
Physiology
Concepts & Ideas
Anatomy
Sign-in to see full Profile
Network (preview)
29
Bloomfield, Clara
28
Wetzler, Meir
20
Sait, Sheila
17
O'Loughlin, Kieran
16
Minderman, Hans
16
Barcos, Maurice
14
Schiffer, Charles Alan
13
Mrózek, Krzysztof
12
Herzig, Geoffrey
12
Ford, Laurie
11
Larson, Richard
11
Slack, James
10
Stewart, Carleton
9
Kolitz, Jonathan
9
McCarthy, Philip
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Maria Baer (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Badros Ashraf; Burger Angelika M; Philip Sunita; Niesvizky Ruben; Kolla Sarah S; Goloubeva Olga; Harris Carolynn; Zwiebel James; Wright John J; Espinoza-Delgado Igor; Baer Maria R; Holleran Julianne L; Egorin Merrill J; Grant Steven
Phase I study of vorinostat in combination with bortezomib for relapsed and refractory multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(16):5250-7.
-
2009: Lancet Jeffrey E; Baer Maria R; Duran George E; List Alan F; Fielding Robert; Marcelletti John F; Multani Pratik S; Sikic Branimir I
A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia.
Leukemia research 2009;33(8):1055-61.
-
2009: Marcelletti John F; Multani Pratik S; Lancet Jeffrey E; Baer Maria R; Sikic Branimir I
Leukemic blast and natural killer cell P-glycoprotein function and inhibition in a clinical trial of zosuquidar infusion in acute myeloid leukemia.
Leukemia research 2009;33(6):769-74.
-
2009: Bunimovich Olga; Grassi Marcelle; Baer Maria R
Systemic mastocytosis: classification, pathogenesis, diagnosis, and treatment.
Cutis; cutaneous medicine for the practitioner 2009;83(1):29-36.
-
2008: Badros Ashraf; Terpos Evangelos; Katodritou Eirini; Goloubeva Olga; Kastritis Efstathios; Verrou Evgenia; Zervas Kostas; Baer Maria R; Meiller Timothy; Dimopoulos Meletios A
Natural history of osteonecrosis of the jaw in patients with multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(36):5904-9.
-
2008: Padmanabhan Aruna; Baker Julie A; Zirpoli Gary; Sait Sheila N J; Ford Laurie A; Moysich Kirsten B; Baer Maria R
Acute myeloid leukemia and myelodysplastic syndrome following breast cancer: increased frequency of other cancers and of cancers in multiple family members.
Leukemia research 2008;32(12):1820-3.
-
2008: Link Petra A; Baer Maria R; James Smitha R; Jones David A; Karpf Adam R
p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia.
Cancer research 2008;68(22):9358-66.
-
2008: Burcu M; O'Loughlin K L; Ford L A; Baer M R
Amonafide L-malate is not a substrate for multidrug resistance proteins in secondary acute myeloid leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(11):2110-5.
-
2008: Baer Maria R; George Stephen L; Caligiuri Michael A; Sanford Ben L; Bothun Sandra M; Mrózek Krzysztof; Kolitz Jonathan E; Powell Bayard L; Moore Joseph O; Stone Richard M; Anastasi John; Bloomfield Clara D; Larson Richard A
Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4934-9.
-
2008: Paschka Peter; Marcucci Guido; Ruppert Amy S; Whitman Susan P; Mrózek Krzysztof; Maharry Kati; Langer Christian; Baldus Claudia D; Zhao Weiqiang; Powell Bayard L; Baer Maria R; Carroll Andrew J; Caligiuri Michael A; Kolitz Jonathan E; Larson Richard A; Bloomfield Clara D
Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(28):4595-602.
-
2008: Badros Ashraf; Goloubeva Olga; Terpos Evangelos; Milliron Todd; Baer Maria R; Streeten Elizabeth
Prevalence and significance of vitamin D deficiency in multiple myeloma patients.
British journal of haematology 2008;142(3):492-4.
-
2008: Arana-Yi Cecilia; Block Annemarie W; Sait Sheila N; Ford Laurie A; Barcos Maurice; Baer Maria R
Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: possible role of cytarabine.
Leukemia research 2008;32(7):1043-8.
-
2008: Pawarode Attaphol; Baer Maria
T/B and not T/B: high frequency of B-cell dyscrasias in T-LGL leukemia.
Leukemia & lymphoma 2008;49(5):845-6.
-
2008: Ramkumar Bhuvaneswari; Chadha Manpreet K; Barcos Maurice; Sait Sheila N J; Heyman Meyer R; Baer Maria R
Acute promyelocytic leukemia after mitoxantrone therapy for multiple sclerosis.
Cancer genetics and cytogenetics 2008;182(2):126-9.
-
2008: Wijermans P W; Rüter B; Baer M R; Slack J L; Saba H I; Lübbert M
Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML).
Leukemia research 2008;32(4):587-91.
-
2007: Pawarode Attaphol; Sait Sheila N J; Nganga Alain; Coignet Lionel J; Barcos Maurice; Baer Maria R
Acute myeloid leukemia developing during imatinib mesylate therapy for chronic myeloid leukemia in the absence of new cytogenetic abnormalities.
Leukemia research 2007;31(11):1589-92.
-
2007: Sait Sheila N J; Claydon Melinda A; Conroy Jeffrey M; Nowak Norma J; Barcos Maurice; Baer Maria R
Translocation (4;11)(p12;q23) with rearrangement of FRYL and MLL in therapy-related acute myeloid leukemia.
Cancer genetics and cytogenetics 2007;177(2):143-6.
-
2007: Minderman Hans; Zhou Yunfei; O'Loughlin Kieran L; Baer Maria R
Bortezomib activity and in vitro interactions with anthracyclines and cytarabine in acute myeloid leukemia cells are independent of multidrug resistance mechanisms and p53 status.
Cancer chemotherapy and pharmacology 2007;60(2):245-55.
-
2007: Pawarode Attaphol; Shukla Suneet; Minderman Hans; Fricke Stacy M; Pinder Elaine M; O'Loughlin Kieran L; Ambudkar Suresh V; Baer Maria R
Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins.
Cancer chemotherapy and pharmacology 2007;60(2):179-88.
-
2007: Weiss Joli R; Baer Maria R; Ambrosone Christine B; Blanco Javier G; Hutson Alan; Ford Laurie A; Moysich Kirsten B
Concordance of pharmacogenetic polymorphisms in tumor and germ line DNA in adult patients with acute myeloid leukemia.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(5):1038-41.
-
2007: Liu Weiguo; Baer Maria R; Bowman Mary Jo; Pera Paula; Zheng Xiang; Morgan Janet; Pandey Ravindra A; Oseroff Allan R
The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(8):2463-70.
-
2007: Ailawadhi S; Sung K-W; Carlson L A; Baer M R
Serotonin syndrome caused by interaction between citalopram and fentanyl.
Journal of clinical pharmacy and therapeutics 2007;32(2):199-202.
-
2007: Brooks Tracy A; O'Loughlin Kieran L; Minderman Hans; Bundy Brian N; Ford Laurie A; Vredenburg Michael R; Bernacki Ralph J; Priebe Waldemar; Baer Maria R
The 4'-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells.
Investigational new drugs 2007;25(2):115-22.
-
2006: Li Yulin; Moysich Kirsten B; Baer Maria R; Weiss Joli R; Brasure John; Graham Saxon; McCann Susan E
Intakes of selected food groups and beverages and adult acute myeloid leukemia.
Leukemia research 2006;30(12):1507-15.
-
2006: Wetzler Meir; Brady Michael T; Tracy Erin; Li Zhang-Rong; Donohue Kathleen A; O'Loughlin Kieran L; Cheng Yijun; Mortazavi Amir; McDonald Amy A; Kunapuli Padmaja; Wallace Paul K; Baer Maria R; Cowell John K; Baumann Heinz
Arsenic trioxide affects signal transducer and activator of transcription proteins through alteration of protein tyrosine kinase phosphorylation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(22):6817-25.
-
2006: Qadir Misbah; Barcos Maurice; Stewart Carleton C; Sait Sheila N J; Ford Laurie A; Baer Maria R
Routine immunophenotyping in acute leukemia: Role in lineage assignment and reassignment.
Cytometry. Part B, Clinical cytometry 2006;70(5):329-34.
-
2006: Cheng Jinrong; Hylander Bonnie L; Baer Maria R; Chen Xing; Repasky Elizabeth A
Multiple mechanisms underlie resistance of leukemia cells to Apo2 Ligand/TRAIL.
Molecular cancer therapeutics 2006;5(7):1844-53.
-
2006: Farag Sherif S; Archer Kellie J; Mrózek Krzysztof; Ruppert Amy S; Carroll Andrew J; Vardiman James W; Pettenati Mark J; Baer Maria R; Qumsiyeh Mazin B; Koduru Prasad R; Ning Yi; Mayer Robert J; Stone Richard M; Larson Richard A; Bloomfield Clara D
Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.
Blood 2006;108(1):63-73.
-
2006: Pawarode Attaphol; Finlay Esme; Sait Sheila N J; Barcos Maurice; Baer Maria R
Isochromosome 1q in a myelodysplastic syndrome after treatment for acute promyelocytic leukemia.
Cancer genetics and cytogenetics 2006;167(2):155-60.
-
2006: Ramanarayanan Jeyanthi; Dunford Lauren M; Baer Maria R; Sait Sheila N J; Lawrence William; McCarthy Philip L
Chronic myeloid leukemia after treatment of lymphoid malignancies: response to imatinib mesylate and favorable outcomes in three patients.
Leukemia research 2006;30(6):701-5.
-
2006: Weiss Joli R; Baker Julie A; Baer Maria R; Menezes Ravi J; Nowell Susan; Moysich Kirsten B
Opposing effects of aspirin and acetaminophen use on risk of adult acute leukemia.
Leukemia research 2006;30(2):164-9.
-
2006: Greenberg Peter L; Baer Maria R; Bennett John M; Bloomfield Clara D; De Castro Carlos M; Deeg H Joachim; Devetten Marcel P; Emanuel Peter D; Erba Harry P; Estey Eli; Foran James; Gore Steven D; Millenson Michael; Navarro Willlis H; Nimer Stephen D; O'Donnell Margaret R; Saba Hussain I; Spiers Kathy; Stone Richard M; Tallman Martin S
Myelodysplastic syndromes clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(1):58-77.
-
2006: O'Donnell Margaret R; Appelbaum Frederick R; Baer Maria R; Byrd John C; Coutre Steven E; Damon Lloyd E; Erba Harry P; Estey Eli; Foran James; Lancet Jeffrey; Maness Lori J; Maslak Peter G; Millenson Michael; Moore Joseph O; Przepiorka Donna; Shami Paul; Smith B Douglas; Stone Richard M; Tallman Martin S
Acute myeloid leukemia clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(1):16-36.
-
2006: Minderman Hans; O'Loughlin Kieran L; Smith Patrick F; Pendyala Lakshmi; Greco William R; Sweeney Kimberly G; Ford Laurie A; Wetzler Meir; Baer Maria R
Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemia.
Cancer chemotherapy and pharmacology 2006;57(1):73-83.
-
2005: Baer Maria R
Clinical significance of multidrug resistance in AML: current insights.
Clinical advances in hematology & oncology : H&O 2005;3(12):910-2.
-
2005: Marcucci Guido; Baldus Claudia D; Ruppert Amy S; Radmacher Michael D; Mrózek Krzysztof; Whitman Susan P; Kolitz Jonathan E; Edwards Colin G; Vardiman James W; Powell Bayard L; Baer Maria R; Moore Joseph O; Perrotti Danilo; Caligiuri Michael A; Carroll Andrew J; Larson Richard A; de la Chapelle Albert; Bloomfield Clara D
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9234-42.
-
2005: Pawarode A; Baer M R; Padmanabhan S; Wallace P K; Barcos M; Sait S N J; Block A W; Wetzler M; Battiwalla M
Simultaneous presentation of acute monoblastic leukemia and mantle cell lymphoma: case report and review of the literature.
Leukemia & lymphoma 2005;46(12):1813-8.
-
2005: Deeb George; Baer Maria R; Gaile Daniel P; Sait Sheila N Jani; Barcos Maurice; Wetzler Meir; Conroy Jeffrey M; Nowak Norma J; Cowell John K; Cheney Richard T
Genomic profiling of myeloid sarcoma by array comparative genomic hybridization.
Genes, chromosomes & cancer 2005;44(4):373-83.
-
2005: Minderman Hans; Conroy Jeffrey M; O'Loughlin Kieran L; McQuaid Devin; Quinn Paul; Li Song; Pendyala Lakshmi; Nowak Norma J; Baer Maria R
In vitro and in vivo irinotecan-induced changes in expression profiles of cell cycle and apoptosis-associated genes in acute myeloid leukemia cells.
Molecular cancer therapeutics 2005;4(6):885-900.
-
2005: Moore Joseph O; George Stephen L; Dodge Richard K; Amrein Philip C; Powell Bayard L; Kolitz Jonathan E; Baer Maria R; Davey Frederick R; Bloomfield Clara D; Larson Richard A; Schiffer Charles A
Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222.
Blood 2005;105(9):3420-7.
-
2005: Eberl Margaret M; Baer Maria R; Mahoney Martin C; Sait Sheila N J; Block Annemarie W; Farrell Carolyn D
Unsuspected Klinefelter syndrome diagnosed during oncologic evaluation: a case series.
The Journal of the American Board of Family Practice / American Board of Family Practice 2005;18(2):132-9.
-
2005: Qadir Misbah; O'Loughlin Kieran L; Fricke Stacy M; Williamson Nicole A; Greco William R; Minderman Hans; Baer Maria R
Cyclosporin A is a broad-spectrum multidrug resistance modulator.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(6):2320-6.
-
2005: Ojima Iwao; Borella Christopher P; Wu Xinyuan; Bounaud Pierre-Yves; Oderda Cecilia Fumero; Sturm Matthew; Miller Michael L; Chakravarty Subrata; Chen Jin; Huang Qing; Pera Paula; Brooks Tracy A; Baer Maria R; Bernacki Ralph J
Design, synthesis and structure-activity relationships of novel taxane-based multidrug resistance reversal agents.
Journal of medicinal chemistry 2005;48(6):2218-28.
-
2005: Hahn T; Benekli M; Wong C; Moysich K B; Hyland A; Michalek A M; Alam A; Baer M R; Bambach B; Czuczman M S; Wetzler M; Becker J L; McCarthy P L
A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease.
Bone marrow transplantation 2005;35(6):557-66.
-
2005: Shaukat Aasma; Bakri Faris; Young Paul; Hahn Theresa; Ball Donna; Baer Maria R; Wetzler Meir; Slack James L; Loud Peter; Czuczman Myron; McCarthy Philip L; Walsh Thomas J; Segal Brahm H
Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristics.
Mycopathologia 2005;159(2):181-8.
-
2005: Farag Sherif S; Ruppert Amy S; Mrózek Krzysztof; Mayer Robert J; Stone Richard M; Carroll Andrew J; Powell Bayard L; Moore Joseph O; Pettenati Mark J; Koduru Prasad R K; Stamberg Judith; Baer Maria R; Block Annemarie W; Vardiman James W; Kolitz Jonathan E; Schiffer Charles A; Larson Richard A; Bloomfield Clara D
Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):482-93.
-
2004: Hahn Theresa; Alam Arif Raza; Lawrence David; Ford Laurieann; Baer Maria R; Bambach Barbara; Bernstein Zale P; Czuczman Myron S; Silva Joaquin; Slack James L; Wetzler Meir; Becker Joanne; McCarthy Philip L
Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion.
Transplantation 2004;78(10):1515-22.
-
2004: Suvannasankha Attaya; Minderman Hans; O'Loughlin Kieran L; Nakanishi Takeo; Ford Laurie A; Greco William R; Wetzler Meir; Ross Douglas D; Baer Maria R
Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease-free survival.
British journal of haematology 2004;127(4):392-8.
-
2004: Suvannasankha A; Minderman H; O'Loughlin K L; Nakanishi T; Greco W R; Ross D D; Baer M R
Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and function.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(7):1252-7.
-
2004: Sekeres Mikkael A; Peterson Bercedis; Dodge Richard K; Mayer Robert J; Moore Joseph O; Lee Edward J; Kolitz Jonathan; Baer Maria R; Schiffer Charles A; Carroll Andrew J; Vardiman James W; Davey Frederick R; Bloomfield Clara D; Larson Richard A; Stone Richard M;
Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia.
Blood 2004;103(11):4036-42.
-
2004: Suvannasankha Attaya; Minderman Hans; O'Loughlin Kieran L; Sait Sheila N J; Stewart Carleton C; Greco William R; Baer Maria R
Expression of the neural cell adhesion molecule CD56 is not associated with P-glycoprotein overexpression in core-binding factor acute myeloid leukemia.
Leukemia research 2004;28(5):449-55.
-
2004: Minderman Hans; Brooks Tracy A; O'Loughlin Kieran L; Ojima Iwao; Bernacki Ralph J; Baer Maria R
Broad-spectrum modulation of ATP-binding cassette transport proteins by the taxane derivatives ortataxel (IDN-5109, BAY 59-8862) and tRA96023.
Cancer chemotherapy and pharmacology 2004;53(5):363-9.
-
2004: Dibo Imad; Pillai Satish K; Gold Howard S; Baer Maria R; Wetzler Meir; Slack James L; Hazamy Peggy A; Ball Donna; Hsiao Chiu Bin; McCarthy Philip L; Segal Brahm H
Linezolid-resistant Enterococcus faecalis isolated from a cord blood transplant recipient.
Journal of clinical microbiology 2004;42(4):1843-5.
-
2004: Brooks Tracy A; Kennedy Daniel R; Gruol Donald J; Ojima Iwao; Baer Maria R; Bernacki Ralph J
Structure-activity analysis of taxane-based broad-spectrum multidrug resistance modulators.
Anticancer research 2004;24(2A):409-15.
-
2004: Minderman Hans; O'Loughlin Kieran L; Pendyala Lakshmi; Baer Maria R
VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(5):1826-34.
-
2004: Iyer Renuka V; Sait Sheila N J; Matsui Sei-Ichi; Block AnneMarie W; Barcos Maurice; Slack James L; Wetzler Meir; Baer Maria R
Massive hyperdiploidy and tetraploidy in acute myelocytic leukemia and myelodysplastic syndrome.
Cancer genetics and cytogenetics 2004;148(1):29-34.
-
2004: Kolitz J E; George S L; Baer M R; Lee E J; Bloomfield C D; Larson R A;
P-glycoprotein (Pgp) modulation in untreated acute myeloid leukemia (AML): Cancer and Leukemia Group B (CALGB) trials in younger and older adults.
Annals of hematology 2004;83 Suppl 1():S103-4.
-
2003: Brooks Tracy A; Minderman Hans; O'Loughlin Kieran L; Pera Paula; Ojima Iwao; Baer Maria R; Bernacki Ralph J;
Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein.
Molecular cancer therapeutics 2003;2(11):1195-205.
-
2003: Hahn T; Rondeau C; Shaukat A; Jupudy V; Miller A; Alam A R; Baer M R; Bambach B; Bernstein Z; Chanan-Khan A A; Czuczman M S; Slack J; Wetzler M; Mookerjee B K; Silva J; McCarthy P L
Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients.
Bone marrow transplantation 2003;32(4):405-10.
-
2003: Shaukat Aasma; Benekli Mustafa; Vladutiu Georgirene D; Slack James L; Wetzler Meir; Baer Maria R
Simvastatin-fluconazole causing rhabdomyolysis.
The Annals of pharmacotherapy 2003;37(7-8):1032-5.
-
2003: Hahn T; Bunworasate U; George M C; Bir A S; Chinratanalab W; Alam A R; Bambach B; Baer M R; Slack J L; Wetzler M; Becker J L; McCarthy P L
Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftment.
Bone marrow transplantation 2003;32(2):145-50.
-
2003: Wetzler M; McElwain B K; Stewart C C; Blumenson L; Mortazavi A; Ford L A; Slack J L; Barcos M; Ferrone S; Baer M R
HLA-DR antigen-negative acute myeloid leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(4):707-15.
-
2003: Benekli Mustafa; Baer Maria R; Baumann Heinz; Wetzler Meir
Signal transducer and activator of transcription proteins in leukemias.
Blood 2003;101(8):2940-54.
-
2002: Farag Sherif S; George Stephen L; Lee Edward J; Baer Maria; Dodge Richard K; Becknell Brian; Fehniger Todd A; Silverman Lewis R; Crawford Jeffrey; Bloomfield Clara D; Larson Richard A; Schiffer Charles A; Caligiuri Michael A
Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(9):2812-9.
-
2002: Baer Maria R
Detection of minimal residual disease in acute myeloid leukemia.
Current oncology reports 2002;4(5):398-402.
-
2002: Baer Maria R; George Stephen L; Dodge Richard K; O'Loughlin Kieran L; Minderman Hans; Caligiuri Michael A; Anastasi John; Powell Bayard L; Kolitz Jonathan E; Schiffer Charles A; Bloomfield Clara D; Larson Richard A
Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720.
Blood 2002;100(4):1224-32.
-
2002: Minderman Hans; Suvannasankha Attaya; O'Loughlin Kieran L; Scheffer George L; Scheper Rik J; Robey Robert W; Baer Maria R
Flow cytometric analysis of breast cancer resistance protein expression and function.
Cytometry 2002;48(2):59-65.
-
2002: Sait Sheila N J; Qadir Misbah U; Conroy Jeffrey M; Matsui Sei-Ichi; Nowak Norma J; Baer Maria R
Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndrome: identification of new amplification regions by fluorescence in situ hybridization and spectral karyotyping.
Genes, chromosomes & cancer 2002;34(1):42-7.
-
2002: Block AnneMarie W; Carroll Andrew J; Hagemeijer Anne; Michaux Lucienne; van Lom Kirsten; Olney Harold J; Baer Maria R
Rare recurring balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop.
Genes, chromosomes & cancer 2002;33(4):401-12.
-
2002: Benekli Mustafa; Xia Zheng; Donohue Kathleen A; Ford Laurie A; Pixley Lynda A; Baer Maria R; Baumann Heinz; Wetzler Meir
Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival.
Blood 2002;99(1):252-7.
-
2001: Bunworasate U; Arnouk H; Minderman H; O'Loughlin K L; Sait S N; Barcos M; Stewart C C; Baer M R
Erythropoietin-dependent transformation of myelodysplastic syndrome to acute monoblastic leukemia.
Blood 2001;98(12):3492-4.
-
2001: Stone R M; Berg D T; George S L; Dodge R K; Paciucci P A; Schulman P P; Lee E J; Moore J O; Powell B L; Baer M R; Bloomfield C D; Schiffer C A
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine.
Blood 2001;98(3):548-53.
-
2001: Kolte B; Baer A N; Sait S N; O'Loughlin K L; Stewart C C; Barcos M; Wetzler M; Baer M R
Acute myeloid leukemia in the setting of low dose weekly methotrexate therapy for rheumatoid arthritis.
Leukemia & lymphoma 2001;42(3):371-8.
-
2001: Baer M R; Stewart C C; Dodge R K; Leget G; Sulé N; Mrózek K; Schiffer C A; Powell B L; Kolitz J E; Moore J O; Stone R M; Davey F R; Carroll A J; Larson R A; Bloomfield C D
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361).
Blood 2001;97(11):3574-80.
-
2001: Barone S; Baer M R; Sait S N; Lawrence D; Block A W; Wetzler M
High-dose cytosine arabinoside and idarubicin treatment of chronic myeloid leukemia in myeloid blast crisis.
American journal of hematology 2001;67(2):119-24.
-
2001: Xia Z; Sait S N; Baer M R; Barcos M; Donohue K A; Lawrence D; Ford L A; Block A M; Baumann H; Wetzler M
Truncated STAT proteins are prevalent at relapse of acute myeloid leukemia.
Leukemia research 2001;25(6):473-82.
-
2001: Simon M; Hahn T; Ford L A; Anderson B; Swinnich D; Baer M R; Bambach B; Bernstein S H; Bernstein Z P; Czuczman M S; Slack J L; Wetzler M; Herzig G; Schriber J; McCarthy P L
Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin.
Bone marrow transplantation 2001;27(6):627-33.
-
2001: Xia Z; Salzler R R; Kunz D P; Baer M R; Kazim L; Baumann H; Wetzler M
A novel serine-dependent proteolytic activity is responsible for truncated signal transducer and activator of transcription proteins in acute myeloid leukemia blasts.
Cancer research 2001;61(4):1747-53.
-
2001: Wetzler M; Baer M R; Stewart S J; Donohue K; Ford L; Stewart C C; Repasky E A; Ferrone S
HLA class I antigen cell surface expression is preserved on acute myeloid leukemia blasts at diagnosis and at relapse.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(1):128-33.
-
2000: Appelbaum F R; Baer M R; Carabasi M H; Coutre S E; Erba H P; Estey E; Glenn M J; Kraut E H; Maslak P; Millenson M; Miller C B; Saba H I; Stone R; Tallman M S;
NCCN Practice Guidelines for Acute Myelogenous Leukemia.
Oncology (Williston Park, N.Y.) 2000;14(11A):53-61.
-
1999: Schriber J; Milk B; Shaw D; Christiansen N; Baer M; Slack J; Tezcan H; Wetzler M; Herzig G
Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation.
Bone marrow transplantation 1999;24(12):1311-4.
-
1999: Byrd J C; Dodge R K; Carroll A; Baer M R; Edwards C; Stamberg J; Qumsiyeh M; Moore J O; Mayer R J; Davey F; Schiffer C A; Bloomfield C D
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(12):3767-75.
-
1999: Lee E J; George S L; Caligiuri M; Szatrowski T P; Powell B L; Lemke S; Dodge R K; Smith R; Baer M; Schiffer C A
Parallel phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age or older with acute myeloid leukemia: results of cancer and leukemia group B study 9420.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2831-9.
-
1999: Vidal C; Baer M R; Bloomfield C D
Uncommon patterns of presentation of leukemia.
Hematological oncology 1999;17(1):11-29.
-
1999: Wetzler M; Baer M R
Thrombopoietin receptor in acute myeloid leukemia.
Leukemia research 1999;23(2):191-4.
-
1999: Alidina A; Lawrence D; Ford L A; Baer M R; Bambach B; Bernstein S H; Czuczman M S; Slack J L; Spangenthal E; Wetzler M; Barcos M P; Proulx G M; Anderson B; McCarthy P L
Thiotepa-associated cardiomyopathy during blood or marrow transplantation: association with the female sex and cardiac risk factors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(5):322-7.
-
1999: Bernstein S H; Fay J; Frankel S; Christiansen N; Baer M R; Jacobs C; Blosch C; Hanna R; Herzig G
A phase I study of recombinant human soluble interleukin-1 receptor (rhu IL-1R) in patients with relapsed and refractory acute myeloid leukemia.
Cancer chemotherapy and pharmacology 1999;43(2):141-4.
-
1998: Shah M; Jenis E H; Mookerjee B K; Schriber J R; Baer M R; Herzig G P; Wetzler M
Interferon-alpha-associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy.
Cancer 1998;83(9):1938-46.
-
1998: Wetzler M; Bernstein S H; Baumann H; Fries K M; Stewart C; Blumenson L; Baer M R; Herzig G P; Bloomfield C D; Slack J L
Expression and function of the megakaryocyte growth and development factor receptor in acute myeloid leukemia blasts.
Leukemia & lymphoma 1998;30(5-6):415-31.
-
1998: Xia Z; Baer M R; Block A W; Baumann H; Wetzler M
Expression of signal transducers and activators of transcription proteins in acute myeloid leukemia blasts.
Cancer research 1998;58(14):3173-80.
-
1998: Sood R; Stewart C C; Aplan P D; Murai H; Ward P; Barcos M; Baer M R
Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cells.
Blood 1998;91(9):3372-8.
-
1998: Baer M R; Stewart C C; Lawrence D; Arthur D C; Mrózek K; Strout M P; Davey F R; Schiffer C A; Bloomfield C D
Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(3):317-25.
-
1998: Baer M R
Assessment of minimal residual disease in patients with acute leukemia.
Current opinion in oncology 1998;10(1):17-22.
-
1998: Caligiuri M A; Strout M P; Lawrence D; Arthur D C; Baer M R; Yu F; Knuutila S; Mrózek K; Oberkircher A R; Marcucci G; de la Chapelle A; Elonen E; Block A W; Rao P N; Herzig G P; Powell B L; Ruutu T; Schiffer C A; Bloomfield C D
Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics.
Cancer research 1998;58(1):55-9.
-
1997: Baer M R; Stewart C C; Lawrence D; Arthur D C; Byrd J C; Davey F R; Schiffer C A; Bloomfield C D
Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22).
Blood 1997;90(4):1643-8.
-
1997: Wetzler M; Baer M R; Bernstein S H; Blumenson L; Stewart C; Barcos M; Mrózek K; Block A W; Herzig G P; Bloomfield C D
Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2262-8.
-
1997: Byrd J C; Weiss R B; Arthur D C; Lawrence D; Baer M R; Davey F; Trikha E S; Carroll A J; Tantravahi R; Qumsiyeh M; Patil S R; Moore J O; Mayer R J; Schiffer C A; Bloomfield C D
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):466-75.
-
1996: Jurlander J; Caligiuri M A; Ruutu T; Baer M R; Strout M P; Oberkircher A R; Hoffmann L; Ball E D; Frei-Lahr D A; Christiansen N P; Block A M; Knuutila S; Herzig G P; Bloomfield C D
Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia.
Blood 1996;88(6):2183-91.
-
1996: Caligiuri M A; Strout M P; Schichman S A; Mrózek K; Arthur D C; Herzig G P; Baer M R; Schiffer C A; Heinonen K; Knuutila S; Nousiainen T; Ruutu T; Block A W; Schulman P; Pedersen-Bjergaard J; Croce C M; Bloomfield C D
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11.
Cancer research 1996;56(6):1418-25.
-
1996: Baer M R; Bernstein S H; Brunetto V L; Heinonen K; Mrózek K; Swann V L; Minderman H; Block A W; Pixley L A; Christiansen N P; Fay J W; Barcos M; Rustum Y; Herzig G P; Bloomfield C D
Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemia.
Blood 1996;87(4):1484-94.
-
1995: Davey F R; Abraham N; Brunetto V L; MacCallum J M; Nelson D A; Ball E D; Griffin J D; Baer M R; Wurster-Hill D; Mayer R J
Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study.
American journal of hematology 1995;49(1):29-38.
-
1994: Caligiuri M A; Schichman S A; Strout M P; Mrózek K; Baer M R; Frankel S R; Barcos M; Herzig G P; Croce C M; Bloomfield C D
Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations.
Cancer research 1994;54(2):370-3.
-
1993: Baer M R; Christiansen N P; Frankel S R; Brunetto V L; Mrózek K; Bloomfield C D; Herzig G P
High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia.
Seminars in oncology 1993;20(6 Suppl 8):6-12.
-
1993: Xiao H; Baer M R; Block A W; Sait S N; Kakati S
Deletion of chromosome 22 without bcr rearrangement and without juxtaposition of c-abl in a case of acute myeloid leukemia.
Cancer genetics and cytogenetics 1993;67(2):141-4.
-
1993: Baer M R
Management of unusual presentations of acute leukemia.
Hematology/oncology clinics of North America 1993;7(1):275-92.
-
1992: Baer M R; Ozer H; Foon K A
Interferon-alpha therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia.
British journal of haematology 1992;81(2):167-9.
-
1992: Baer M R; Bloomfield C D
Controversies in transfusion medicine. Prophylactic platelet transfusion therapy: pro.
Transfusion 1992;32(4):377-80.
-
1992: Baer M R; Bloomfield C D
Trisomy 13 in acute leukemia.
Leukemia & lymphoma 1992;7(1-2):1-6.
-
1992: Baer M R; Augustinos P; Kinniburgh A J
Defective c-myc and c-myb RNA turnover in acute myeloid leukemia cells.
Blood 1992;79(5):1319-26.
-
1992: Baer M R; Bloomfield C D
Cytogenetics and oncogenes in leukemia.
Current opinion in oncology 1992;4(1):24-32.
-
1991: Chen Z; Morgan R; Baer M R; Ligorsky R; Sandberg A A
Translocation (3;21) characterizes crises in myeloid stem cell disorders.
Cancer genetics and cytogenetics 1991;57(2):153-9.
-
1991: Baer M R; Bloomfield C D
Acute promyelocytic leukemia: an update.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(6):392-3.
-
1991: Baer M R
Normal full-term pregnancy in a patient with chronic myelogenous leukemia treated with alpha-interferon.
American journal of hematology 1991;37(1):66.
-
1991: Baer M R; Bloomfield C D
Multidrug resistance in acute myeloid leukemia.
Journal of the National Cancer Institute 1991;83(10):663-5.
-
1991: Baer M R; Bloomfield C D
The clinical use of cytogenetics in acute leukemia.
Annals of medicine 1991;23(2):117-9.
-
1991: Baer M R; Bloomfield C D
The clinical significance of biological characteristics of the cells in acute myeloid leukemia.
Annual review of medicine 1991;42():381-9.
-
1990: Sreekantaiah C; Baer M R; Morgan S; Isaacs J D; Miller K B; Sandberg A A
Trisomy/tetrasomy 13 in seven cases of acute leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1990;4(11):781-5.
-
1990: Baer M R; Sreekantaiah C; Jani Sait S N; Sawyer A M; Block A; Sandberg A A; Preisler H D
Cytogenetic study of maturing granulocytes in bone marrow of patients with acute myelogenous leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1990;4(4):297-301.
-
1990: Jacob A K; Sreekantaiah C; Baer M R; Sandberg A A
Translocation (1;6)(p12;p23) in ANLL.
Cancer genetics and cytogenetics 1990;45(1):67-71.
-
1989: Baer M R; Barcos M; Farrell H; Raza A; Preisler H D
Acute myelogenous leukemia with leukemia cutis. Eighteen cases seen between 1969 and 1986.
Cancer 1989;63(11):2192-200.
-
1989: Sreekantaiah C; Baer M R; Preisler H D; Sandberg A A
Involvement of bands 9q21-q22 in five cases of acute nonlymphocytic leukemia.
Cancer genetics and cytogenetics 1989;39(1):55-64.
-
1989: Sreekantaiah C; Han T; Baer M R; Sandberg A A
Acute nonlymphocytic leukemia in a patient with a constitutional inv(4).
Cancer genetics and cytogenetics 1989;39(1):119-23.
-
1989: Baer M R; Gao X Z; Sato H; Singh P; Preisler H D
Proto-oncogene expression during early myeloid differentiation of normal peripheral blood progenitor cells.
Leukemia research 1989;13(2):165-72.
-
1988: Sreekantaiah C; Baer M R; Solé F; Preisler H D; Sandberg A A
Translocation (2;7)(p13;q36) in a case of acute nonlymphocytic leukemia evolving from a myelodysplastic syndrome.
Cancer genetics and cytogenetics 1988;35(2):199-204.
-
1988: Kaufman D C; Baer M R; Gao X Z; Wang Z Q; Preisler H D
Enhanced expression of the granulocyte-macrophage colony stimulating factor gene in acute myelocytic leukemia cells following in vitro blast cell enrichment.
Blood 1988;72(4):1329-32.
-
1988: Dessypris E N; Brenner D E; Baer M R; Hande K R
Uptake and intracellular distribution of doxorubicin metabolites in B-lymphocytes of chronic lymphocytic leukemia.
Cancer research 1988;48(3):503-6.
-
1988: Fan Y S; Baer M R; Sait S N; Dal Cin P; Prentice T C; Preisler H D; Sandberg A A
An acquired Robertsonian translocation dic(14;14)(p11;p11) in a patient with a myelodysplastic syndrome following treatment of multiple myeloma.
Cancer genetics and cytogenetics 1988;30(1):133-7.
-
1988: Baer M R; Gao X Z; Preisler H D
Sustained viability of acute myelogenous leukemia cells in liquid suspension culture correlates with occurrence of differentiation.
Leukemia research 1988;12(8):647-50.
-
1987: Baer M R; Dessypris E N; Stein R S; Cousar J B; Krantz S B
Variable differentiation patterns of acute myelogenous leukaemia blasts in liquid suspension cultures.
British journal of haematology 1987;66(2):179-85.
-
1987: Baer M R; Gleaton J H; Salhany K E; Glick A D
Malignant histiocytosis occurring with acute myelogenous leukemia in a patient with longstanding polycythemia vera.
Cancer 1987;59(3):489-95.
-
1986: Stein R S; Greer J P; Ferrin W; Lenox R; Baer M R; Flexner J M
Clinical experience with amphotericin B in acute myelogenous leukemia.
Southern medical journal 1986;79(7):863-70.
-
1986: Baer M R; Dessypris E N
Deletion of the long arm of chromosome 5 (5q-) as a secondary event in the course of refractory anemia.
Cancer genetics and cytogenetics 1986;22(2):169-76.
-
1986: Baer M R; Stein R S; Greer J P; Wolff S N; Hainsworth J D; Flexner J M
Modified cyclophosphamide, vincristine, methotrexate, leucovorin, and cytarabine (COMLA) in intermediate- and high-grade lymphoma: an effective short-course regimen.
Cancer treatment reports 1986;70(6):785-7.
-
1986: Baer M R; Krantz S B; Cousar J B; Glick A D; Collins R D
Malignant histiocytoses developing in patients with B-cell lymphomas. Report of two cases.
Cancer 1986;57(11):2175-84.
-
1985: Baer M R; Stein R S; Dessypris E N
Chronic lymphocytic leukemia with hyperleukocytosis. The hyperviscosity syndrome.
Cancer 1985;56(12):2865-9.
-
1985: Baer M R; King L E; Wolff S N
Palmar-plantar erythrodysesthesia and cytarabine.
Annals of internal medicine 1985;102(4):556.
-
1985: Stein R S; Baer M R; Flexner J M
Improved survival in adult acute lymphoblastic leukemia. Need for more effective CNS prophylaxis.
American journal of clinical oncology 1985;8(2):162-6.
-
1984: Dessypris E N; Baer M R; Sergent J S; Krantz S B
Rheumatoid arthritis and pure red cell aplasia.
Annals of internal medicine 1984;100(2):202-6.
Sign-in to see more
